FLASCO 2025 Clinical Oncology Series: Neuro-Oncology

The FLASCO Clinical Oncology Series: Neuro-Oncology is an advanced educational program designed to provide healthcare professionals with a comprehensive understanding of the complex field of neuro-oncology. This series focuses on the diagnosis, treatment, and management of primary and secondary tumors of the central nervous system (CNS), including gliomas, meningiomas, metastases, and rare neuro-oncologic conditions. Tailored for oncologists, neurologists, neurosurgeons, oncology nurses, and other healthcare providers involved in neuro-oncology, the program will offer in-depth insights into the latest diagnostic tools, cutting-edge treatment strategies, and emerging therapies. Attendees will explore advancements in surgical techniques, radiation therapy, chemotherapy, and immunotherapy for CNS cancers, with a focus on multidisciplinary approaches to improve patient outcomes and quality of life. 

*Biopharmaceutical industry attendance is restricted to event sponsors only. For sponsorship information, please email katrina@flasco.org